Cargando...

Efficacy Endpoints in Clinical Trials in Actinic Keratosis

INTRODUCTION: Actinic keratosis is regarded as a chronic disease of the skin and, although fluctuating, is chronically progressive. Approval of new products for the treatment of actinic keratosis requires the use of a standard methodology in clinical trials which emphasize complete clearance of all...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Dermatol Ther (Heidelb)
Main Authors: Skov, Torsten, Stockfleth, Eggert, Szeimies, Rolf-Markus, Berman, Brian
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6109027/
https://ncbi.nlm.nih.gov/pubmed/29916197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-018-0247-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!